Pediatric tolerability profile
REACTINE® is generally well tolerated by children
Most common adverse reactions reported in placebo-controlled pediatric REACTINE® trials
Adverse Experience | Placebo (N=239) | Cetirizine 5 mg (N=161) | Cetirizine 10 mg (N=144) |
Headache | 10.9 | 11.2 | 12.5 |
Abdominal pain | 2.1 | 4.4 | 6.3 |
Pharyngitis | 3.8 | 6.2 | 4.2 |
Coughing | 3.4 | 4.4 | 3.5 |
Epistaxis | 2.5 | 3.7 | 2.8 |
Somnolence | 0.8 | 1.9 | 4.2 |
Nausea | 2.1 | 1.9 | 4.2 |
Adapted from the REACTINE® Product Monograph. 2023.
References
1. REACTINE® Product Monograph. Johnson & Johnson Consumer Inc. 2023.